Dermata Therapeutics Inc - Warrants (13/08/2026)
DRMAW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.41K
Close$
$2.07
344300% upside
Current Fair Value
344300% upsideUndervalued by 344300% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2,413.00 |
|---|---|
| Enterprise Value | $-4,410,351.00 |
| Earnings per Share | $-8.16 |
| Beta | 0.66 |
| Outstanding Shares | 4,022,143 |
Return
| Return on Equity | -239.95% |
|---|---|
| Return on Assets | -157.28% |
| Return on Invested Capital | -244.64% |
Valuation & Multiples
| P/E Ratio | -0.18 |
|---|---|
| PEG | -0.24 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.55
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-0.55
Consensus analyst estimateRevenue Estimate
$25,000
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.34%▼ 0.00% |
|---|---|
| Total Invested | $142▼ 41.56% |
| Investors Holding | 20% |
About Dermata Therapeutics Inc
2,021 employees
